These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32445525)

  • 1. Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply.
    Dong C; Metzger M; Holsbø EE; Perduca V; Carbonnel F
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1445-1446. PubMed ID: 32445525
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply.
    Jairath V; Vande Casteele N; Hindryckx P
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1170-1171. PubMed ID: 28326588
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: acute severe ulcerative colitis - should all patients be treated equally? Authors' reply.
    Lynch RW; Arnott ID
    Aliment Pharmacol Ther; 2014 Jan; 39(1):114. PubMed ID: 24299326
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: infliximab in severe ulcerative colitis - is it useful for all patients? Authors' reply.
    Sjöberg M; Halfvarson J; Tysk C
    Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1413-4. PubMed ID: 24206380
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: long-term outcomes of patients with acute severe ulcerative colitis after intravenous steroid therapy-authors' reply.
    Amiot A; Salameh R
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1252. PubMed ID: 33016556
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? Authors' reply.
    Katsuno T; Saito K; Yokosuka O
    Aliment Pharmacol Ther; 2013 Jan; 37(1):161. PubMed ID: 23205481
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply.
    Yamamoto T; Shimoyama T; Umegae S; Matsumoto K
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1243. PubMed ID: 27137731
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: factors that may predict response to ciclosporin in ulcerative colitis - authors' reply.
    Katsuno T; Saito K; Yokosuka O
    Aliment Pharmacol Ther; 2013 Mar; 37(6):655. PubMed ID: 23406409
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply.
    Croft A; Walsh A; Doecke J; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Oct; 38(8):993. PubMed ID: 24074312
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - authors' reply.
    Schmidt KJ; Fellermann K; Büning J
    Aliment Pharmacol Ther; 2013 Feb; 37(4):502. PubMed ID: 23336691
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysis. Authors' reply.
    Sebastian S; Myers S
    Aliment Pharmacol Ther; 2020 Mar; 51(6):666-667. PubMed ID: 32100353
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Azathioprine-induced pancreatitis and subsequent tolerance of mercaptopurine--authors' reply.
    Kennedy NA; Lees CW
    Aliment Pharmacol Ther; 2014 Feb; 39(4):440-1. PubMed ID: 24447316
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply.
    Yamamoto T; Shimoyama T; Umegae S; Matsumoto K
    Aliment Pharmacol Ther; 2016 May; 43(9):1017-8. PubMed ID: 27040167
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: predictors of severe disease in ulcerative colitis - the same or different in Crohn's disease? Authors' reply.
    Khan N; Almukhtar RM
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1121-2. PubMed ID: 25280262
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: comparative efficacy of biological therapy in patients with ulcerative colitis - authors' reply.
    Stidham RW; Lee TC; Higgins PD; Deshpande AR; Sussman DA; Singal AG; Elmunzer BJ; Vijan S; Saini SD; Waljee AK
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1433-4. PubMed ID: 24849156
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: biological drugs for inducing remission in ulcerative colitis - authors' reply.
    Stidham RW; Lee TC; Higgins PD; Deshpande AR; Sussman DA; Singal AG; Elmunzer BJ; Saini SD; Vijan S; Waljee AK
    Aliment Pharmacol Ther; 2014 May; 39(10):1244. PubMed ID: 24735147
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: how to define remission in ulcerative colitis - histological remission should be considered. Authors' reply.
    Angelison L; Marsal J; Hertervig E
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1177-1178. PubMed ID: 28326579
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?
    Li Wai Suen CFD; Choy MC; De Cruz P
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1444-1445. PubMed ID: 32445527
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: histological assessment of disease activity in ulcerative colitis--the problem of score evaluation and validation; authors' reply.
    Bressenot AM; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2016 Feb; 43(3):439. PubMed ID: 26782113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.